Who owns Carmell Therapeutics Corp - US?

Tip: Access positions for across all investors

Analyze quarterly positions in Carmell Therapeutics Corp - US with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Carmell Therapeutics Corp - US stock

Who bought or sold Carmell Therapeutics Corp - US this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
UBS O'Connor 371k $57k 100% Mar 2024
 View chart
Balyasny Asset Management 343k $52k 0% Mar 2024
 View chart
OZ Management 228k $39k 0% Mar 2024
 View chart
Millennium Management 190k $29k -19% Mar 2024
 View chart
Highbridge Capital Management 182k $28M 0% Mar 2024
 View chart
Exos Asset Management 130k $17k 100% Mar 2024
 View chart
Exos TFP Holdings 130k $30k 0% Dec 2023
 View chart
Citadel Advisors 99k $15k 100% Mar 2024
 View chart
CNH Partners 86k $13k -11% Mar 2024
 View chart
Walleye Trading Advisors 51k $7.8k 0% Mar 2024
 View chart
Cowen And Company 25k $3.8k 0% Mar 2024
 View chart
Saba Capital Management 20k $3.3k 0% Mar 2024
 View chart
Whitebox Advisors 19k $2.9k 0% Mar 2024
 View chart
Clear Street 13k $2.0k 1% Mar 2024
 View chart
Wolverine Asset Management 9.4k $1.4k -12% Mar 2024
 View chart
Ancora Advisors 2.8k $471.120800 0% Mar 2024
 View chart
Bank of America Corporation 100.00 $13.000000 100% Mar 2024
 View chart

Who sold out of Carmell Therapeutics Corp - US?

Fund or Company Name Date Sold Shares Held Valued At
Linden Advisors Sep 2023 371k $93M
Flow Traders US Dec 2023 20k $4.0k